Tonix Eyes TNX‑102 SL Expansion, But We Need To See Tonmya Revenue First

Seeking Alpha is built by investors, for investors, so you can get the insights you need to make smarter investing decisions.
The Manila Times

Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Diabetic neuropathy is a common, progressive complication of diabetes characterized by nerve damage that leads to chronic ...
BioWorld

Shenzhen Newrosetta Biosciences discloses new muscarinic M2 receptor antagonists

Shenzhen Newrosetta Biosciences Co. Ltd. has divulged benzodiazepine derivatives acting as muscarinic M2 receptor antagonists reported to be useful for the treatment of myopia.
Hackaday

New Drug Hopes To Treat Sleep Apnea Without Masks

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...
Pulse Today

How to manage asthma in pregnancy

Respiratory specialists Dr Anna Haley and Dr Nita Sehgal discuss the key principles in management of asthma during pregnancy ...

Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), today announced its participation as a key industry partner in ACCESS-AD, a major new European initiative designed to accelerate ...

Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...